Richter Bromocriptine counteracts endocrine disorders and Parkinsonism. One tablet contains 2.5 milligrams of bromocriptine mesylate.
The drug has a dopamine-mimetic effect, being derived from ergot alkaloids. When using the drug, dopamine postsynaptic receptors are activated, which reduces the production of prolactin in the anterior pituitary gland. The drug is highly effective in the treatment of a variety of menstrual disorders, as well as infertility, which are caused or associated with an increased content of prolactin in the blood. Also, the drug is able to suspend or prevent the production of milk. In addition, growth hormone production decreases in the presence of acromegaly. The drug can have a positive effect in the treatment of Parkinson's disease.
There are the following indications for taking the drug:
- violation of menstruation, infertility, which are associated with increased production of prolactin;
- with mild or absent menstruation, which are combined with non-physiological excretion of milk or without it;
- insufficient luteal phase in the menstrual cycle;
- sclerocystic ovary syndrome ;
- cycles of an involuntary nature;
- pituitary tumors; acromegaly;
- Parkinson's disease of any origin; -
- mastalgia;
- mastopathy.
Regarding the side effects that Richter Bromocriptine gives, the reviews of those who used the drug describe the following possible side effects: vomiting, nausea, headaches, fatigue, dizziness. Antiemetics are recommended for use one hour before taking the drug. Sometimes there is a sharp drop in pressure when changing the position of the body. Large doses of the drug can cause psychosis, hallucinations, dyskinesia, visual disturbances, constipation, dry mouth, cramps in the calf muscles. With prolonged therapy, a manifestation of Raynaud's syndrome is possible .
When using the drug in the field of endocrinology, there are no absolute contraindications. In the case of the use of the drug in Parkinson's disease, there are the following contraindications: tremor, not associated with Parkinson's disease; severe diseases of the cardiovascular system; Hetchinson's chorea: toxicosis of pregnant women; endogenous psychoses; hypersensitivity to the components of the drug.
As for the dosage of the drug "Bromocriptine Richter", the instruction is required to study, since the dosage of the drug depends heavily on what disease it is used against. In any case, the dosage must be agreed with the attending physician.
It is unacceptable to use this drug in conjunction with other forms of ergot derivatives. If the drug is used together with erythromycin, an increase in the concentration of bromocriptine in the blood is not ruled out. A decrease in the concentration of bromocriptine is possible with simultaneous use with antidopamine drugs. If sharing is not possible to avoid, increased control of the attending physician is necessary.
There are several special points that should be considered when taking the drug "Bromocriptine Richter." Reliable contraception should be provided if the drug is used by a woman of childbearing age. If possible, it should not be hormonal. If the patient becomes pregnant and wishes to continue the pregnancy, then the drug should be stopped immediately. However, the use of the drug "Bromocriptine Richter" in the first eight weeks of pregnancy does not affect in any way its outcome. Remember that during pregnancy, caution will never be superfluous.